Immunoreactive Somatostatin is Present in Discrete Cells of the Endocrine Pancreas

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1975 Apr 1

PMID 1093177

Citations 74

Authors

M P Dubois

Affiliations

Soon will be listed here.

Abstract

A discrete population of cells of the endocrine pancreas contains immunoreactive somatostatin as shown by immunofluorescence. These cells are different from those containing glucagon or insulin. This unexpected observation may be of physiopathological significance in the regulatory mechanisms involved in the secretion of glucagon and insulin.

Citing Articles

Paracrine signalling by pancreatic δ cells determines the glycaemic set point in mice.

Huang J, Pourhosseinzadeh M, Lee S, Kramer N, Guillen J, Cinque N Nat Metab. 2024; 6(1):61-77.

PMID: 38195859 PMC: 10919447. DOI: 10.1038/s42255-023-00944-2.

Review: The evolution of peptidergic signaling in Cnidaria and Placozoa, including a comparison with Bilateria.

Hauser F, Koch T, Grimmelikhuijzen C Front Endocrinol (Lausanne). 2022; 13:973862.

PMID: 36213267 PMC: 9545775. DOI: 10.3389/fendo.2022.973862.

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights.

Starr J, Sonbol M, Hobday T, Sharma A, Kendi A, Halfdanarson T Onco Targets Ther. 2020; 13:3545-3555.

PMID: 32431509 PMC: 7205451. DOI: 10.2147/OTT.S202867.

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.

Stueven A, Kayser A, Wetz C, Amthauer H, Wree A, Tacke F Int J Mol Sci. 2019; 20(12).

PMID: 31234481 PMC: 6627451. DOI: 10.3390/ijms20123049.

The Difference δ-Cells Make in Glucose Control.

Huising M, van der Meulen T, Huang J, Pourhosseinzadeh M, Noguchi G Physiology (Bethesda). 2018; 33(6):403-411.

PMID: 30303773 PMC: 6347098. DOI: 10.1152/physiol.00029.2018.

References

WEICHERT 3rd R . The neural ectodermal origin of the peptide-secreting endocrine glands. A unifying concept for the etiology of multiple endocrine adenomatosis and the inappropriate secretion of peptide hormones by nonendocrine tumors. Am J Med. 1970; 49(2):232-41. DOI: 10.1016/s0002-9343(70)80079-1. View

BRAZEAU P, Vale W, Burgus R, Ling N, Butcher M, Rivier J . Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973; 179(4068):77-9. DOI: 10.1126/science.179.4068.77. View

Vale W, BRAZEAU P, Grant G, Nussey A, Burgus R, Rivier J . [Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. C R Acad Hebd Seances Acad Sci D. 1972; 275(25):2913-6. View

Burgus R, Ling N, Butcher M, Guillemin R . Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proc Natl Acad Sci U S A. 1973; 70(3):684-8. PMC: 433335. DOI: 10.1073/pnas.70.3.684. View

Rivier J . Somatostatin. Total solid phase synthesis. J Am Chem Soc. 1974; 96(9):2986-92. DOI: 10.1021/ja00816a053. View